<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39386803</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Liver function abnormality on admission predicts long COVID syndrome in digestive system.</ArticleTitle><Pagination><StartPage>e37664</StartPage><MedlinePgn>e37664</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e37664</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e37664</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Clinical practice showed that many patients with SARS-CoV-2 infection presented with long COVID syndrome in digestive system. We sought to investigate the factor affecting the incidence of long COVID syndrome in digestive system.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="UNASSIGNED">Patients with SARS-CoV-2 infection diagnosed at two centers of Zhongshan Hospital and one center of Shanghai Pudong Hospital from March 01, 2022 to May 31, 2022 were enrolled, collected in the hospital database, and followed up until March 30, 2023. The primary outcome of the study was the occurrence of post-acute sequelae of COVID-19 in the digestive system (long COVID syndrome). Modified Poisson regression was used to calculate the relative risk (RR). This cohort study included 494 patients with SARS-CoV-2 infection, 144 (29.1&#xa0;%) patients developed liver function abnormality on admission. During the follow-up period, the primary study outcome occurred in 30 (20.8&#xa0;%) of the group presenting with liver function abnormality on admission and in 20 (5.7&#xa0;%) of the group without liver function abnormality on admission (adjusted, RR&#xa0;=&#xa0;3.550, 95%CI: 2.099-6.006, <i>P</i>&#xa0;&#x2264;&#xa0;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our study suggests that patients with COVID-19 who experience liver function abnormality on admission have an increased risk of developing long COVID syndrome in the digestive system.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huibin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Shanghai Institute of Liver Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yunjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Wenqing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Shanghai Institute of Liver Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Minzhi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Clinical Research Unit, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Clinical Research Unit, Key Laboratory of Public Health Safety of Ministry of Education, Key Laboratory for Health Technology Assessment, National Commission of Health, School of Public Health, Center of Evidence-Based Medicine, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhixue</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Shanghai Institute of Liver Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Fansheng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yitong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Medicine, Anhui University of Science and Technology, Anhui, 232000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Huajie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Jindan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Anhui University of Science and Technology, Anhui, 232000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingya</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Shanghai Institute of Liver Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Dejun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, 201399, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Si</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Ruyi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Shanghai Institute of Liver Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Baoshan District Wusong Central Hospital (Zhongshan Hospital Wusong Branch, Fudan University), Shanghai, 200940, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Liver function abnormality</Keyword><Keyword MajorTopicYN="N">Long COVID syndrome in the digestive system</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>5</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39386803</ArticleId><ArticleId IdType="pmc">PMC11462002</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e37664</ArticleId><ArticleId IdType="pii">S2405-8440(24)13695-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano J.B., et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., et al. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transduct. Targeted Ther. 2023;8(1):416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10618229</ArticleId><ArticleId IdType="pubmed">37907497</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett J.W., et al. Potential long coronavirus disease 2019 gastrointestinal symptoms 6 Months after coronavirus infection are associated with mental health symptoms. Gastroenterology. 2022;162(2):648&#x2013;650.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., et al. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21(3):133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Parotto M., et al. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir. Med. 2023;11(8):739&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">37475125</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev. Med. Virol. 2022;32(4):e2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Javid Mishamandani Z., et al. Nutritional status of patients hospitalized in the intensive care unit: a comprehensive report from Iranian hospitals, 2018. J. Crit. Care. 2019;54:151&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">31446233</ArticleId></ArticleIdList></Reference><Reference><Citation>Motti M.L., et al. The role of nutrients in prevention, treatment and post-coronavirus disease-2019 (COVID-19) Nutrients. 2022;14(5):1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8912782</ArticleId><ArticleId IdType="pubmed">35267974</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open. 2021;11(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948153</ArticleId><ArticleId IdType="pubmed">33692181</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber S., et al. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study. Gut. 2021;70(10):1925&#x2013;1932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852072</ArticleId><ArticleId IdType="pubmed">33514597</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini R.K., et al. COVID-19 associated variations in liver function parameters: a retrospective study. Postgrad Med J. 2022;98(1156):91&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">33184141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom P.P., et al. Liver biochemistries in hospitalized patients with COVID-19. Hepatology. 2021;73(3):890&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">32415860</ArticleId></ArticleIdList></Reference><Reference><Citation>Imam M.T., et al. COVID-19 and severity of liver diseases: possible crosstalk and clinical implications. Int Immunopharmacol. 2023;121</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10247890</ArticleId><ArticleId IdType="pubmed">37315370</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei H.Y., et al. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed. Pharmacother. 2021;133</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7700011</ArticleId><ArticleId IdType="pubmed">33378966</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed U., et al. SARS-CoV-2 induced hepatic injuries and liver complications. Front. Cell. Infect. Microbiol. 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9523111</ArticleId><ArticleId IdType="pubmed">36189356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong P., et al. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct. Targeted Ther. 2020;5(1):256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605138</ArticleId><ArticleId IdType="pubmed">33139693</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., et al. COVID-19-associated liver injury: clinical characteristics, pathophysiological mechanisms and treatment management. Biomed. Pharmacother. 2022;154</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9381432</ArticleId><ArticleId IdType="pubmed">36029543</ArticleId></ArticleIdList></Reference><Reference><Citation>Drain P.K. Rapid diagnostic testing for SARS-CoV-2. N. Engl. J. Med. 2022;386(3):264&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820190</ArticleId><ArticleId IdType="pubmed">34995029</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission and National Administration of Traditional Chinese Medicine Novel coronavirus pneumonia diagnosis and treatment protocol (trial 9th edition) Chinese Journal of Viral Diseases. 2022;12(3):161&#x2013;169. (in Chinese)</Citation></Reference><Reference><Citation>Yip T.C., et al. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. Gut. 2021;70(4):733&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pubmed">32641471</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X., et al. 12-Month post-discharge liver function test abnormalities among patients with COVID-19: a single-center prospective cohort study. Front. Cell. Infect. Microbiol. 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046934</ArticleId><ArticleId IdType="pubmed">35493732</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., et al. Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study. Emerg Microbes Infect. 2022;11(1):2680&#x2013;2688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639507</ArticleId><ArticleId IdType="pubmed">36215047</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., et al. Efficacy and safety of glycyrrhizic acid preparation treating comorbid liver injury in COVID-19: a systematic review. Front. Pharmacol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9669476</ArticleId><ArticleId IdType="pubmed">36408213</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y., et al. Clinical features of patients infected with coronavirus disease 2019 with elevated liver biochemistries: a multicenter, retrospective study. Hepatology. 2021;73(4):1509&#x2013;1520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361581</ArticleId><ArticleId IdType="pubmed">32602604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Z.Y., et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J. Hepatol. 2021;74(6):1295&#x2013;1302.26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7749734</ArticleId><ArticleId IdType="pubmed">33347952</ArticleId></ArticleIdList></Reference><Reference><Citation>The Joint Prevention and Control Mechanism Group of the State Council to COVID-19, New Coronavirus Pneumonia Prevention and Control Plan. ninth ed.) Chinese Journal of Viral Diseases; 2022. pp. 331&#x2013;338. (in Chinese) 12(05)</Citation></Reference><Reference><Citation>Juno J.A., Wheatley A.K. Boosting immunity to COVID-19 vaccines. Nat. Med. 2021;27(11):1874&#x2013;1875.</Citation><ArticleIdList><ArticleId IdType="pubmed">34764485</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M., et al. Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds. GeroScience. 2022;44(3):1229&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990277</ArticleId><ArticleId IdType="pubmed">35394604</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S.J., et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine through 6 months. N. Engl. J. Med. 2021;385(19):1761&#x2013;1773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461570</ArticleId><ArticleId IdType="pubmed">34525277</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergstra S.A., et al. Three handy tips and a practical guide to improve your propensity score models. RMD Open. 2019;5(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6525599</ArticleId><ArticleId IdType="pubmed">31168417</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.W., Acharya K.P. Propensity score matching for causal inference and reducing the confounding effects: statistical standard and guid eline of Life Cycle Committee. Life Cycle. 2022;2:e18.</Citation></Reference><Reference><Citation>Zhu L., et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068&#x2013;1077.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252168</ArticleId><ArticleId IdType="pubmed">32369736</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione, L., et al., Liver involvement and mortality in COVID-19: a retrospective analysis from the CORACLE study group. Infezioni Med. Le. 30(1): p. 80-85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8929727</ArticleId><ArticleId IdType="pubmed">35350260</ArticleId></ArticleIdList></Reference><Reference><Citation>Chela H.K., et al. Liver injury on admission linked to worse outcomes in COVID-19: an analysis of 14,138 patients. Transl Gastroenterol Hepatol. 2023;8:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9813654</ArticleId><ArticleId IdType="pubmed">36704655</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzobon, F.M., et al., Liver injury predicts overall mortality in severe COVID-19: a prospect ive multicenter study in Brazil. Hepatology international. 15(2): p. 493-501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857099</ArticleId><ArticleId IdType="pubmed">33534084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripon S., et al. Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19. Clin Res Hepatol Gastroenterol. 2022;46(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8873041</ArticleId><ArticleId IdType="pubmed">35227956</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida, Y., et al., Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19. J. Gastroenterol. 55(11): p. 1098-1106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7415328</ArticleId><ArticleId IdType="pubmed">32776161</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term gastrointestinal outcomes of COVID-19. Nat. Commun. 2023;14(1):983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9992516</ArticleId><ArticleId IdType="pubmed">36882400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.S., et al. Long-Term autoimmune inflammatory rheumatic outcomes of COVID-19 : a binational cohort study. Ann. Intern. Med. 2024;177(3):291&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">38437702</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q., et al. COVID-19: abnormal liver function tests. J. Hepatol. 2020;73(3):566&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194951</ArticleId><ArticleId IdType="pubmed">32298767</ArticleId></ArticleIdList></Reference><Reference><Citation>Cholongitas E., et al. Prevalence of abnormal liver biochemistry and its impact on COVID-19 patients' outcomes: a single-center Greek study. Ann. Gastroenterol. 2022;35(3):290&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9062840</ArticleId><ArticleId IdType="pubmed">35599935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferm S., et al. Analysis of gastrointestinal and hepatic manifestations of SARS-CoV-2 infection in 892 patients in queens, NY. Clin. Gastroenterol. Hepatol. 2020;18(10):2378&#x2013;2379 e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263206</ArticleId><ArticleId IdType="pubmed">32497637</ArticleId></ArticleIdList></Reference><Reference><Citation>Hundt M.A., et al. Abnormal liver tests in COVID-19: a retrospective observational cohort study of 1,827 patients in a major U.S. Hospital network. Hepatology. 2020;72(4):1169&#x2013;1176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258788</ArticleId><ArticleId IdType="pubmed">32725890</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., et al. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients. Mil Med Res. 2020;7(1):28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276224</ArticleId><ArticleId IdType="pubmed">32507110</ArticleId></ArticleIdList></Reference><Reference><Citation>Du C., et al. Clinical course and risk factors for liver injury of severe and critical patients with COVID-19. Infect. Drug Resist. 2022;15:7025&#x2013;7035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724580</ArticleId><ArticleId IdType="pubmed">36483143</ArticleId></ArticleIdList></Reference><Reference><Citation>Radivojevic A., et al. A systematic review of SARS-CoV-2-associated hepatic dysfunction and the impact on the clinical outcome of COVID-19. Cureus. 2022;14(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9375135</ArticleId><ArticleId IdType="pubmed">35974857</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Zompo F., et al. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 2020;24(24):13072&#x2013;13088.</Citation><ArticleIdList><ArticleId IdType="pubmed">33378061</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N., et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28(1):423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews N., et al. Duration of protection against mild and severe disease by covid-19 vaccines. N. Engl. J. Med. 2022;386(4):340&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8781262</ArticleId><ArticleId IdType="pubmed">35021002</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden L.R., et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 2021;384(5):403&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Efe C., et al. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis. J. Autoimmun. 2022;132</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9448709</ArticleId><ArticleId IdType="pubmed">36088883</ArticleId></ArticleIdList></Reference><Reference><Citation>John B.V., et al. Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Intern. Med. 2021;181(10):1306&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278308</ArticleId><ArticleId IdType="pubmed">34254978</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G., et al. Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave. Emerg Microbes Infect. 2022;11(1):2045&#x2013;2054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9448390</ArticleId><ArticleId IdType="pubmed">35924388</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. 2022;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Z., et al. Influenza vaccination hesitancy and its determinants among elderly in China: a national cross-sectional study. Vaccine. 2022;40(33):4806&#x2013;4815.</Citation><ArticleIdList><ArticleId IdType="pubmed">35788295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying C.Q., et al. Intentions of patients with hypertension to receive a booster dose of the COVID-19 vaccine: a cross-sectional survey in taizhou, China. Vaccines (Basel) 2022;10(10):1635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9608070</ArticleId><ArticleId IdType="pubmed">36298500</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., et al. Inactivated vaccines reduce the risk of liver function abnormality in NAFLD patients with COVID-19: a multi-center retrospective study. EBioMedicine. 2023;99</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10758750</ArticleId><ArticleId IdType="pubmed">38096688</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., et al. Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytes. Signal Transduct. Targeted Ther. 2024;9(1):42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10866945</ArticleId><ArticleId IdType="pubmed">38355848</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao N., et al. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat. Commun. 2021;12(1):1618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955129</ArticleId><ArticleId IdType="pubmed">33712622</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., et al. SARS-CoV-2 RNA stabilizes host mRNAs to elicit immunopathogenesis. Mol Cell. 2024;84(3):490&#x2013;505.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">38128540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Z., et al. Clinical features of COVID-19-related liver functional abnormality. Clin. Gastroenterol. Hepatol. 2020;18(7):1561&#x2013;1566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194865</ArticleId><ArticleId IdType="pubmed">32283325</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: the Beijing experience. J. Autoimmun. 2020;112</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7180376</ArticleId><ArticleId IdType="pubmed">32439209</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., et al. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020;40(9):2095&#x2013;2103.</Citation><ArticleIdList><ArticleId IdType="pubmed">32239796</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>